Money Talks News on MSN12h
Unexpected Brain Boost? Shingrix Vaccine Shows Promise Against DementiaNew study reveals potential cognitive benefits of Shingrix vaccine. The shingles shot may offer protection against dementia, ...
When Nancy Greeley was in her 50s, her sister, an infectious-disease specialist at the University of Rochester, told her to ...
Co-administration of the RSV and shingles adjuvanted vaccines was well tolerated, with acceptable reactogenicity and safety ...
On3 on MSN1h
Report: FedEx continuing to reduce sponsorship presence with Joe Gibbs Racing, could sever ties altogetherFedEx is reportedly set to continue reducing its sponsorship presence with Joe Gibbs Racing after this season, with the ...
GSK touts co-administration data for RSV, shingles vaccines as narrowed CDC guidance threatens sales
In the study, co-administration of GSK's RSV vaccine Arexvy and shingles shot Shingrix elicited non-inferior immune responses ...
If approved, the co-administration of Arexvy and Shingrix could provide a more convenient vaccination regimen for patients ...
Zacks.com on MSN5d
GSK Meets Study Goal for Co-Administered RSV-Shingles VaccinesData from a late-stage study shows that co-administering GSK's RSV and Shingles vaccines together was as effective as giving ...
2 SHINGRIX is approved for the prevention of shingles (herpes zoster) in adults aged 50 years and older. AREXVY is approved for the prevention of lower respiratory tract disease (LRTD) caused by ...
Melbourne, Australia The Government has expanded access to GSK's shingles vaccine, Shingrix, to cover individuals aged 18 ...
GSK (GSK) reached the main goal in a Phase 3 trial for its RSV shot, Arexvy co--administered with Shingles vaccine Shingrix.
GSK plc (NYSE:GSK) released topline data from the phase 3 trial in adults 50 years and older evaluating the immunogenicity, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback